The production cost of Doxazosin is not publicly disclosed by manufacturers. However, Doxazosin is a well-established generic medication, which generally implies lower production costs compared to newer, branded drugs.
How Doxazosin's Generic Status Affects Pricing
As a generic drug, Doxazosin has been available for many years, with its patents having long expired. This allows multiple pharmaceutical companies to manufacture and sell the drug, leading to a competitive market that drives down prices [1]. The production cost for these generic versions is typically lower due to optimized manufacturing processes and economies of scale [2].
What is Doxazosin Used For?
Doxazosin is a medication used to treat high blood pressure (hypertension) and symptoms of an enlarged prostate (benign prostatic hyperplasia, or BPH) [3]. It works by relaxing blood vessels, which lowers blood pressure, and by relaxing muscles in the prostate and bladder neck, which improves urine flow [4].
When Did Doxazosin Patents Expire?
The original patents for Doxazosin have long expired, allowing for generic production. For instance, the extended-release formulation of Doxazosin (Cardura XL) saw patent challenges and generic entry around the mid-2010s [5]. Detailed patent expiry information for specific formulations can be found on resources like DrugPatentWatch.com [6].
What Are Doxazosin's Alternatives?
For hypertension, other classes of medications are available, including ACE inhibitors, ARBs, calcium channel blockers, and diuretics. For BPH, alternatives include 5-alpha reductase inhibitors and other alpha-blockers [3]. The choice of medication depends on individual patient needs and medical conditions.
Who Manufactures Doxazosin?
Numerous pharmaceutical companies produce generic Doxazosin. Major generic manufacturers, such as Teva Pharmaceuticals, Aurobindo Pharma, and Mylan (now Viatris), are among those that offer Doxazosin in various forms [7].